Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Petershill Partners to quit London stock market

(Sharecast News) - Petershill Partners is to delist from the London stock market, the British investment firm announced on Thursday, after concluding it was undervalued as a public company. Founded by Goldman Sachs in 2007, the firm - which remains majority owned by the Wall Street bank - made its London debut in September 2021.

Since then, Petershill said assets under management had reached $351bn, at an annualised growth rate of 17%.

However, it argued that despite a "strong" operating and financial performance, the firm's share price and valuation had not reflected the quality or underlying value of its assets, financial performance or growth prospects.

The board has therefore opted to delist the business, returning around $921m in cash returned to shareholders.

Under the proposed terms, freefloat shareholders will receive $4.15 in cash for every ordinary share cancelled.

Combined with the $0.052 interim dividend, the offer represents a premium of around 35% to Wednesday's closing price and values Petershill at around $4.5bn.

As at 0830 BST, shares in Petershill had rocketed 33% at 307.58p.

In a joint statement, Ali Raissi-Dehkordy and Robert Hamilton Kelly, co-heads of Goldman Sachs Petershill Group, said: "The operator agrees that this is in the best interests of the company, free-float shareholders and shareholders as a whole.

"The board and operator believe the company has been consistently undervalued despite strong delivery of its strategy and that this is a unique opportunity to return significant near-term value to free-float shareholders."

The firm also published interim results on Thursday, showing partner distributable earnings of $152m in the six months to 30 June, up 9%.

Adjusted earnings before interest and tax rose to $167m from $128m, with a margin of 89% and adjusted earnings per share of 11.4 cents, up from 8.5 cents.

Total capital return was $265m.

Raissi-Dehkordy and Hamilton Kelly said: "We are pleased that our partner-firms have raised $19bn of gross fee-eligible assets in the first half, despite volatile markets earlier in the year."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.